...
首页> 外文期刊>Japanese journal of clinical oncology. >Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: impact of nodal density and total tumor volume.
【24h】

Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: impact of nodal density and total tumor volume.

机译:晚期化学强化方案治疗的局部晚期头颈癌患者的预后变量分析:淋巴结密度和总肿瘤体积的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The aim of the present study was to define the prognostic impact of nodal density (ND) and total tumor volume along with many other tumor, treatment and patient related variables using the late chemo-intensification treatment regimen with conventionally fractionated radiotherapy (70 Gy/7 weeks). METHODS: A total of 74 patients with Stage III and IV biopsy proven squamous cell carcinoma of oropharynx, hypopharynx and larynx were treated with this regimen. ND and total tumor volume was measured on high resolution CT scans for all the patients. Chemotherapy consisted of continuous infusion of 5 FU at 350 mg/m(2)/day and cisplatin as 1 h infusion at 10 mg/m(2)/day on days 1-5 of week 6 and 7 of radiotherapy. RESULTS: Grade III mucositis was present in 48 (64.9%) patients. Overall complete response rate was 77%. At 28 months, locoregional relapse-free survival (LRFS), overall survival (OS) and distant metastases-free survival (DMFS) was 70.8%, 66.9% and 81.9%, respectively. In the final multivariate Cox-regression model tumor stage, ND, primary site and nodal stage were independent variables predicting for LRFS. Similarly AJCC group staging, ND and total treatment volume were found to have significant impact, independently over LRFS. CONCLUSIONS: There is tremendous variation in terms of ND and total tumor volume within AJCC nodal staging and tumor staging, respectively. ND had significant impact over LRFS and OS. Future phase III trial may need stratification on the basis of these variables.
机译:目的:本研究的目的是采用常规分次放疗(70 Gy)的晚期化学强化治疗方案确定淋巴结密度(ND)和总肿瘤体积以及许多其他肿瘤,治疗和患者相关变量对预后的影响/ 7周)。方法:该方案共治疗74例经III期和IV期活检证实为口咽,下咽和喉鳞状细胞癌的患者。在所有患者的高分辨率CT扫描中测量ND和总肿瘤体积。化学疗法包括在放疗的第6周和第7天的第1-5天以350 mg / m(2)/天的量连续注入5 FU,以10 mg / m(2)/天的量连续1小时注入顺铂。结果:48(64.9%)位患者存在III级粘膜炎。总体总答复率为77%。在28个月时,局部无复发生存率(LRFS),总生存率(OS)和远处无转移生存率(DMFS)分别为70.8%,66.9%和81.9%。在最终的多变量Cox回归模型肿瘤阶段,ND,主要部位和淋巴结阶段是预测LRFS的独立变量。同样地,发现AJCC组的分期,ND和总治疗量对LRFS有明显影响。结论:在AJCC淋巴结分期和肿瘤分期中,ND和总肿瘤体积分别存在巨大差异。 ND对LRFS和OS产生了重大影响。在这些变量的基础上,将来的III期试验可能需要分层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号